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Norihito Wada1, Hirofumi Kawakubo1, Tai Omori1, Hiroya Takeuchi1, Aya Sasaki2 and Yuko Kitagawa1Abstract
Intra-abdominal desmoid tumors are rare and most often occur in patients with a history of familial adenomatous
polyposis, surgery, or pregnancy. We report a case of an intra-abdominal desmoid tumor mimicking the recurrence
of gastric cancer. A 57-year-old male had undergone distal gastrectomy for advanced gastric cancer. Serum levels
of carcinoembryonic antigen were found to be elevated 27 months after surgery. Computed tomography revealed
a 15-mm mass in the mesentery of the transverse colon. In addition, radiotracer fluorodeoxyglucose uptake of the
tumor was detected by positron emission tomography. The patient was diagnosed with gastric cancer recurrence,
and chemotherapy consisting of cisplatin and S-1 was commenced. After five courses of chemotherapy, although
no significant clinical response was seen, no new lesions were seen either. Thus, a curative resection of the
recurrent tumor seemed possible, which was successfully performed. Histological examination of the resected
specimen revealed spindle-shaped tumor cells with collagen fiber progression; no cancer cells were detected.
The tumor was diagnosed as an intra-abdominal desmoid tumor. We report a rare case of an intra-abdominal
desmoid tumor that mimicked a recurrent tumor arising from gastric cancer. In patients with history of surgery for
intra-abdominal malignancies, it may be difficult to distinguish the recurrence of malignancy from desmoid tumors
but the possibility of desmoid tumors must be considered in the differential diagnosis.
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Desmoid tumors are rare connective tissue tumors that
occur most often in patients with a history of familial
adenomatous polyposis (FAP), surgery, or pregnancy [1].
Although they are histologically benign and non meta-
static, they are locally invasive. Few reports exist on intra-
abdominal desmoid tumor that mimics gastric cancer
recurrence after gastrectomy [2-4]. In this report, we
report a rare case of an intra-abdominal desmoid tumor
that mimicked a recurrent tumor arising from gastric
cancer.Case presentation
A 57-year-old male patient had undergone distal gastrec-
tomy and D2 lymphadenectomy for advanced gastric
cancer. A postoperative abdominal abscess presented* Correspondence: tsunehiro-t@a8.keio.jp
1Department of Surgery, School of Medicine, Keio University, 35
Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
Full list of author information is available at the end of the article
© 2014 Okamura et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.around the pancreatic head, which was improved by
conservative therapy. Histopathological examination of
the tumor revealed a poorly differentiated adenocarcin-
oma; the tumor was classified as stage IB (pT2N0M0)
according to the 7th TNM classification of the Inter-
national Union Against Cancer [5]. Because a curative
resection was performed, adjuvant chemotherapy was not
administered (according to the Japanese gastric cancer
treatment guidelines 2010 [6]). His follow up for recurrence
included analysis of serum carcinoembryonic antigen
(CEA) level every 3 months and computed tomography
(CT) and/or ultrasonography every 6 months. At 27 months
after gastrectomy, an increase in serum CEA level was
detected during follow up (Figure 1). CT and positron
emission tomography (PET) were subsequently performed.
CT revealed a solitary, localized mass measuring 15 mm
in diameter in the mesentery of the transverse colon
(Figure 2a). Radiotracer fluorodeoxyglucose (FDG) up-
take of this tumor was seen (Figure 2b) during the PET
study. The maximum standard uptake value (SUV max)al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Figure 1 The changes in serum carcinoembryonic antigen level
after gastrectomy. CEA, carcinoembryonic antigen.
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We considered that this tumor was a recurrence, in the
lymph node or peritoneum, of the previous gastric cancer.
We initiated first-line chemotherapy consisting of cisplatin
and S-1 for five cycles. Serum CEA levels slightly de-
creased (Figure 1). However, no clinical response was
observed in image inspections (Figure 2c, d); the tumor
was noted to have slightly enlarged, but no new lesions
were observed. Because curative resection seemed pos-
sible, we decided to completely resect the tumor. The
tumor strongly adhered to the transverse colon; therefore,
this part of the transverse colon was also removed.Figure 2 Abdominal computed tomography (CT) and positron emissi
and localized tumor in the mesentery of the transverse colon 27 months a
uptake of the tumor (arrow). (c) CT and (d) PET of the tumor after five cou
was seen (arrow).Macroscopically, the tumor was hard and elastic,
measuring 40 × 30 × 30 mm. The cut surface was whitish
and poorly circumscribed with surrounding adipose tis-
sue (Figure 3a). Histological examination revealed prolif-
eration of spindle-shaped cells and collagenous stroma
(Figure 3b, c). No nuclear hyperchromasia or atypia was
observed in these cells. Immunohistological examination
revealed that the cells were focally positive for α-smooth
muscle actin, negative for keratin, and nuclei-positive
for beta-catenin (Figure 3d). The tumor was diagnosed as
desmoid-type fibromatosis, also known as a desmoid
tumor. No cancer cells were detected in the resected spe-
cimen. The patient’s postoperative course was favorable,
and there was no evidence of recurrence of gastric cancer
and desmoid tumor after 6 months.
Discussion
Desmoid tumors are rare connective tissue tumors
involving the muscloaponeurotic tissues; they are benign
and non metastatic but locally invasive and tend to
recur. They account for 0.03% of all newly diagnosed
neoplasms [7] and 3% of all soft tissue neoplasms [8,9].
The etiology of desmoid tumors, which are predomin-
antly found in young female patients of reproductive
age, is unknown. However, they are strongly associated
with endocrine factors, FAP, and trauma (including sur-
gical incision) [1]. In this case, there is no family history
of FAP. In addition, the patient had no colonic lesion
evident on colonoscopy, which was performed routinely
as a preoperative inspection. Therefore, our case was noton tomography (PET) of the desmoid tumor. (a) CT shows a solitary
fter gastrectomy (arrow). (b) PET shows radiotracer fluorodeoxyglucose





Figure 3 Pathologic features of the desmoid tumor. (a) Macroscopically, a 40 × 30 × 30 mm hard elastic tumor was seen in the mesentery of
the transverse colon. The cut surface is whitish and poorly circumscribed with surrounding adipose tissue. (b, c) Histologically, proliferation of
spindle-shaped cells with collagenous stroma is seen (hematoxylin and eosin staining; b: low-power field, c: high-power field). (d) Immunohistological
examination revealed that the cell nuclei were positive for beta-catenin.
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correlation between desmoid tumors and the infectious
complications of previous surgery, it is possible that the
etiology in our case could be related to intra-abdominal
infection rather than surgical incision.
Intra-abdominal desmoid tumors mimicking gastric
cancer recurrence after gastrectomy are very rare, and
few cases have been reported [2-4]. In the case presented
here, on identifying a solitary mass in the mesentery of
the transverse colon, we initially thought it to be tumor
recurrence (such as recurrent lymph node metastasis or
peritoneal dissemination) - the diagnosis of desmoid
tumor was never considered. In relation to other malig-
nancies such as colorectal and renal cancer [10-12],
there are also only a few cases of intra-abdominal des-
moid tumors mimicking tumor recurrence after previous
surgery. Therefore, postoperative intra-abdominal des-
moid tumors in patients with history of surgery for intra-
abdominal malignancies are not well known. However,
despite an extremely low incidence, it is clear that postop-
erative desmoid tumors should be included in the differ-
ential diagnoses.
The tumor marker CEA is widely used as an indicator
of disease progression or recurrence after resection of
various malignancies. CEA is expressed in some tumors
of epithelial origin, including those of the lung, ovary,
breast, and colorectum; it is also sometimes expressed in
normal tissue [13]. There has been no definitive study
investigating serum CEA level in relation to desmoid tu-
mors; in addition, serum CEA elevation in patients with
desmoid tumors does not seem to be recognized, be-
cause they are not tumors of epithelial origin. Althoughserum CEA was elevated in our patient, the degree of
elevation did not correlate with the tumor size in image
inspections. In addition, we could not find another
lesion that was thought to be a gastric cancer recur-
rence, or other malignancies on CT and PET. Serum
CEA elevation has been associated with several non neo-
plastic conditions, including chronic inflammatory dis-
ease, renal and hepatic insufficiency, aging, and smoking
[14]. The cause of serum CEA elevation in our patient is
uncertain, but it might be related to a non neoplastic
condition.
Diagnostic imaging for tumor assessment includes the
use of CT, magnetic resonance imaging (MRI), and PET.
Desmoid tumors are often inhomogenously enhanced on
contrast CT, hypo-intense on T1-weighted MRI, and
mixed but predominantly hyper-intense on T2-weighted
MRI, reflecting both the proliferation of fibroblasts and
increase of collagen fibers [15,16]. We did not perform
MRI in our patient because we initially believed the
tumor to be a recurrence. However, desmoid tumors do
not show specific findings in diagnostic imaging, and
few cases have been definitively diagnosed before surgi-
cal resection. PET is an imaging modality that has re-
cently began to play an important role in the diagnosis
and staging of various malignancies [17]. SUV is a semi-
quantitative analysis of the degree of metabolic activity
in the abnormal tissues. In general, desmoid tumors
seem to be detected with low FDG uptake, because of
their low malignancy. However, there has been no de-
finitive study investigating the pattern of FDG uptake
and the possible clinical use of PET in diagnosing
desmoid tumors; only a preliminary report exists [18].
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be difficult and can only be established by histological
examination or molecular analysis.
As a treatment strategy, surgical resection using wide
negative margins remains the first-line treatment of intra-
abdominal desmoid tumor [19]; conservative management
strategies for inoperable desmoid tumors remain unclear.
Therefore, it is necessary to detect the tumor early and to
perform appropriate surgical resection in patients present-
ing with desmoid tumor. However, in the case of recur-
rence from previous malignancies, appropriate treatment
should also be performed depending on the type of malig-
nancy and the situation. Although it is difficult to distin-
guish the recurrence of a malignancy from a desmoid
tumor, it is important to consider the possibility of an
intra-abdominal desmoid tumor mimicking tumor recur-
rence when performing a postoperative workup for intra-
abdominal malignancy. If desmoid tumor is even slightly
suspected, surgical resection should be considered.Conclusion
This case presents a rare case of intra-abdominal desmoid
tumor mimicking gastric cancer recurrence after gas-
trectomy. In patients with a history of surgery for intra-
abdominal malignancies, the possibility of postoperative
desmoid tumor should be considered, even though distin-
guishing malignant recurrences from desmoid tumors
remains difficult.Consent
Written informed consent for publication of this case
report and any accompanying images was obtained from
the patient. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.Abbreviations
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